Market Share & Forecast, 2016-26
Global Lateral Epicondylitis (Tennis Elbow) Market Size- Industry
Trends & Forecast Report 2026
market of Lateral Epicondylitis (Tennis Elbow) witness market size of USD 8,953.51
Million in 2019 and projected to reach market size of 1,0397.04 at a CAGR of 2.32%
during the forecast period of 2020-2026. The growing burden of lateral
epicondylitis, increase in target population, and launch of cost-effective
treatment options are the major growth propellers for the market.
In addition, increasing efforts undertaken by major companies for the
development of technological advanced products will also support market growth.
Involvement of international organizations serves as a catalyst in tennis elbow
treatment market. In addition, new product introduction enabling effective
treatment for lateral epicondylitis (tennis elbow) will fuel the growth of
lateral epicondylitis (tennis elbow) market. Some of the drugs under trial
include hyaluronate sodium, botulinum toxin and topical nitrates. The promotion
of physical exercise is an essential strategy of health promotion. Since sports
participation entails the risk of injuries that account for substantial
morbidity and disability, the existence of adequate epidemiological information
is essential for the development of sound preventive strategies. There are
number of other activities responsible for tennis elbow depends upon age group
and activity type.
Global Lateral Epicondylitis (Tennis Elbow) Market: Overview
A common musculoskeletal condition
causing pain and functional weakness is lateral epicondylitis, or tennis elbow.
Caused by repeated arms and elbow movements. A kind of tendinitis, the disease
includes tendon swelling and is diagnosed on medical checkup. Lateral
epicondylitis (tennis elbow) is an inflammatory syndrome usually found in
tennis players, baseball players, swimmers, carpenters, plumbers and anyone who
over and over performs an arm movement.
Pain is localized around the
lateral elbow and dorsal forearm regions. The condition aggravates on extending
wrist against the resistance. Lateral epicondylitis (tennis elbow) can be
diagnosed through medical imaging test such as X-ray, MRI or electromyography
(EMG). Men and women of age group 35 years to 60 years are afflicted with this
condition predominantly. Although different nonsurgical conservative therapies
such as bracing, physical therapy, nonsteroidal anti-inflammatory drugs, and
corticosteroid injections in addition to surgical approaches have been used,
yet there is no standard treatment for lateral epicondylitis.
Increasing Cases of
Lateral Epicondylitis and Sport-Related Injuries
Age and improper equipment used by athletes are
some of the major factors responsible for lateral epicondylitis (tennis elbow).
Moreover, people participating in recreational activities are bound to do
repetitive actions involving the frequent movement of elbow. Risk for lateral
epicondylitis (tennis elbow) is high in this population. In younger people, a
piece of cartilage or bone in the joints may loosen due to osteochondritis
dissecans leading to lateral epicondylitis. As this condition is not limited to
athletes alone, the demand for available and anticipated treatment has
increased substantially in recent years, in turn, driving the expansion of the
global lateral epicondylitis treatment market.
Ø As per the Stanford
Children’s Health, each year around 3.5 million children ages 14 and below are
affected by some form of sport-related injuries. The aforementioned factors are
likely to drive the demand for tennis elbow treatment. Ennis elbow is the most
common cause of elbow symptoms in patients presenting with elbow pain in
Ø The condition tends
to affect men and women equally. Half of tennis players develop pain around the
elbow, of which 75% represent true tennis elbow. It is more common in individuals
older than 40 years of age.
Advancement and favorable Reimbursement
favorable reimbursement from government authority and technological advancement
in the treatment sector becoming a key booster to drive growth trend of lateral
epicondylitis market. Agencies, such as the Centers for Medicare and Medicaid
offer up to 80% reimbursement for knee braces. The aforementioned factors are
driving the demand for the product. New product introduction enabling effective
treatment for lateral epicondylitis (tennis elbow) will fuel the growth of
lateral epicondylitis (tennis elbow) market in upcoming years. Some of the
drugs under trial include hyaluronate sodium, botulinum toxin and topical
nitrates. TENEX procedure is one of the promising procedure, where a needle is
inserted into the injured tendon and ultrasonic energy is used to vibrate the
needle to break up the damaged tissue so that it can be removed.
Sluggish Adoption Trend of New Effective Therapies
Sluggish adoption trend of
new effective therapies is expected to pose hurdle for the growth of this
market over coming few years. The devices are expensive when compared to few of
the alternate methods. Payers, regulators and customers are demanding better
clinical and economic outcomes, while legacy product lines are becoming
commoditized and price erosion is impacting all treatment segments of the
lateral epicondylitis market. Improper diagnosis to differentiate the
requirement of accurate treatment type also impacting market in terms of value
in current and upcoming years.
Epicondylitis (Tennis Elbow) Market: Treatment Type
Based on treatment type the global lateral epicondylitis
market segmented into corticosteroid injection, surgery, therapy, painkillers
and NSAIDS and Equipment's and Other Products. Surgery segment includes
treatment such as arthroscopy, open surgeries etc. that are opted as a final
remedial measure for treating tennis elbow. Technological advancements in the
nature of surgical equipment and guidance systems will support the demand for
these treatment methods. Furthermore, growing preference for minimally invasive
procedures due to advantages such as quicker recuperation, better safety
outcomes, less blood loss and low risk of infection are the major factors that
urge the demand for arthroscopy for tennis elbow treatment.
Epicondylitis (Tennis Elbow) Market: End User
market is segregated into Hospital/Clinic and Pharmacy/Drug Stores. Tie-ups of
government authorities with hospital for player’s safety and insurance driving
growth of hospital segment. The U.S. Department of Health and Human Services’
National Youth Sports Strategy for increasing awareness of the benefits of
participation in sports and regular physical activity, as well as the
importance of good nutrition is boosting the regional growth for the market.
Furthermore, favorable reimbursement scenario bodes a well for brace segment.
Agencies, such as the Centers for Medicare and Medicaid offer up to 80%
reimbursement for knee braces. The aforementioned factors are driving the
demand for the product.
Epicondylitis (Tennis Elbow) Market: Regional Insights
On the geographical region basis,
the global lateral epicondylitis market segmented into North America, Europe,
Asia-Pacific, Latin America and Middle East & Africa. Amidst the segmentation
due to rising disposable income, well establishes healthcare infrastructure and
presence of leading players headquarter in the North America region. Asia-Pacific
projected to grow with significant growth rate in upcoming years with the
increasing trend of government initiatives and medical tourism in the region
due to low cost structure in comparison with developed region. Depending upon the patient condition treatment type varies spray,
therapy, and injection contributing with high market share across the region
while surgery is dominating the regional market. The side effects associated
with corticosteroid injections, painkillers and NSAIDS with temporary relief
property projected to impede market growth in upcoming years with significant
rate in the MEA region.
The global tennis elbow treatment
market is consolidated in nature. Various companies are striving to gain market
share by adopting competitive strategies such as joint ventures and research
partnerships. Some key players operating in the market include Stryker
Corporation, Chugai Pharmaceutical Co., Ltd, Seikagaku Corporation, Teikoku
Seiyaku Co., Ltd., DJO Global, Inc., Zimmer Biomet, Smith & Nephew plc,
Pfizer Inc., 3M Company, Arthrex and other prominent players. Acquisitions and
effective mergers are some of the strategies adopted by the key manufacturers.
New product launches and focuses on continuous technology innovations are also
strategies adopted by the major players. The companies are also trying to
dominate the market by investing in research and development. For instance,
Zimmer Biomet's, Tether treatment of scoliosis, providing a fusion-less
alternative for young patients requiring surgery for young patients with scoliosis
receives FDA approval.
Ø November 2019, Prolotherapy injections and
physiotherapy used singly and in combination for lateral epicondylalgia: a
single-blinded randomised clinical trial.
Ø March 2019, New IR treatment for
'tennis elbow' reduces pain and inflammation without surgery
Sep 2018, Platelet-Rich Plasma (PRP) is
currently being investigated for its effectiveness in speeding the healing of a
variety of tendon injuries
The objective of the Study:
Ø To analyze and forecast the global Lateral
Epicondylitis (Tennis Elbow) market size of the market in terms of value.
Ø To examine the careful market segmentation and
forecast the market size, in terms of value, based on the region by segmenting.
Ø The Global Lateral Epicondylitis (Tennis Elbow) market
segmented into five regions, namely, North America, Europe, Asia Pacific,
Middle East, South America, and their leading countries.
Ø To outline, categorized, and forecast the global Lateral
Epicondylitis (Tennis Elbow) market based on the treatment type and end user
coupled with the region.
Ø To examine competitive developments like
technological advancement, services, and regulative framework within the global
Lateral Epicondylitis (Tennis Elbow) market.
Ø To highlight the impact analysis of the factors
affecting the market dynamics such as drivers, restraints, opportunities, and
Ø To strategically profile the key players and
comprehensively analyze their market shares along with detailing the
competitive landscape for market leaders.
Scope of the Report
Historical data –
Base Year – 2019
– 2020 – 2026
Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China,
India, UAE, South Africa, Saudi Arabia
Type and End-User
Stryker Corporation, Chugai
Pharmaceutical Co., Ltd, Seikagaku Corporation, Teikoku Seiyaku Co., Ltd.,
DJO Global, Inc., Zimmer Biomet, Smith & Nephew plc, Pfizer Inc., 3M
Company, Arthrex and other prominent
Ø Corticosteroid Injections
Ø Therapy (Shock Wave Therapy &
Ø Painkillers and NSAIDS
Ø Equipment's and Other Products
Ø Pharmacy/Drug Stores
Ø North America
Ø Asia Pacific
Ø Latin America
Ø Middle East &